GSK Investigational Site

Bhubaneswar 751019

1 studies enrolling now · 4 studies all time

What they study most

Lung Cancer, Non-Small Cell, Neoplasms, Head and Neck, Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Respiratory Syncytial Virus Infections

Studies at this site

• A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma — Recruiting now
• A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) — Running, not enrolling
• Phase 2b Study of GSK4532990 in Adults With NASH — Running, not enrolling
• A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers — Stopped early